Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark
Anne Troldborg(Aarhus University), Bent Deleuran(Aarhus University), Lauren Remkus, Daniel Eek(AstraZeneca (Sweden))
Cited by 7
Related Papers
Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders
|PEDIATRICS|2009|409
Chitosan/siRNA Nanoparticle–mediated TNF-α Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model
|Molecular Therapy|2008|298
IL-25 in Atopic Dermatitis: A Possible Link between Inflammation and Skin Barrier Dysfunction?
|Journal of Investigative Dermatology|2010|214